Intellia Therapeutics (NTLA) EBT Margin Growth (1y) (2016 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,558.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,688.00
10 Intellia Therapeutics 1.63 Bn 1.63 Bn - 4,134.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4,134.00
Dec 31, 2025 57,657.00
Sep 30, 2025 69,577.00
Jun 30, 2025 109,984.00
Mar 31, 2025 -32,449.00
Dec 31, 2024 -762,481.00
Sep 30, 2024 -46,886.00
Jun 30, 2024 -93,966.00
Mar 31, 2024 44,276.00
Dec 31, 2023 741,915.00
Sep 30, 2023 -20,622.00
Jun 30, 2023 -18,476.00
Mar 31, 2023 48,406.00
Dec 31, 2022 -14,994.00
Sep 30, 2022 2.31 Mn
Jun 30, 2022 35,484.00
Mar 31, 2022 -56,025.00
Dec 31, 2021 1,807.00
Sep 30, 2021 -2.38 Mn
Jun 30, 2021 -85,129.00
Mar 31, 2021 -8,079.00
Dec 31, 2020 -38,120.00
Sep 30, 2020 9,733.00
Jun 30, 2020 3,182.00
Mar 31, 2020 -42,583.00
Dec 31, 2019 -1,660.00
Sep 30, 2019 8,383.00
Jun 30, 2019 5,842.00
Mar 31, 2019 7,563.00
Dec 31, 2018 11,742.00
Sep 30, 2018 -9,659.00
Jun 30, 2018 -2,589.00
Mar 31, 2018 -8,269.00
Dec 31, 2017 -17,165.00
Sep 30, 2017 -5,620.00
Jun 30, 2017 -9,948.00
Mar 31, 2017 17,319.00
Dec 31, 2016 13,662.00
Sep 30, 2016 4,189.00
Jun 30, 2016 8,446.00
Mar 31, 2016 -28,350.00